Myeloid Differentiation
Myeloid Differentiation - Related Videos
10:21
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
0 Views •
Cited by 3 •
2018
Here detailed protocols for culturing the murine myeloid precursor 32D/G-CSF-R cell line, performing viral infections, and carrying out proliferation and differentiation assays are presented. This cell line is suitable for studying myeloid cell development, and the role of genes of interest in myeloid cell growth and neutrophilic differentiation.
01:15
Differentiation of Common Myeloid Progenitor Cells
0 Views •
2023
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
06:39
Culture of myeloid dendritic cells from bone marrow precursors
0 Views •
Cited by 22 •
2008
This video demonstrates the procedure for differentiating myeloid dendritic cells from mouse bone marrow. Isolation of mouse tibia and femur, and processing of bone marrow are demonstrated. Pictures demonstrating cell morphology before and after differentiation, and figures depicting cell phenotype and IL-12 production following maturation using CpG are shown.
05:14
Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo
0 Views •
2025
Given the limited xenograft models available to study interactions between human CART and myeloid cells, we established in vitro and in vivo models to understand the impacts of human macrophages on CART cells. Findings can potentially be generalized to evaluate macrophage roles in the tumor microenvironment and test macrophage-targeted immunotherapies.
04:56
Differentiation of Human-Induced Pluripotent Stem Cells into Macrophages
0 Views •
2025
This video describes an in vitro method for generating macrophages from human induced pluripotent stem cells (iPSCs). Macrophage generation from iPSCs occurs in three stages: (i) aggregation of iPSCs in suspension to form three-dimensional embryoid bodies (EBs) that differentiate into mesodermal cells, (ii) formation of macrophage precursor cells from the differentiated EBs, and (iii) differentiation of the macrophage precursor cells into mature, functional macrophages.
FAQs
Cytokines and lineage-specific transcription factors act as regulatory inputs that guide progenitor cells through ordered developmental decisions. They influence which genes are expressed, how rapidly cells proliferate, and when they acquire mature characteristics. Because these controls operate sequentially rather than as a single switch, changes in regulatory signaling can alter the abundance and properties of resulting myeloid populations.
Progression can be understood as a coordinated sequence of gene-expression changes, cell proliferation, and maturation. These events move progenitor populations from an earlier developmental state toward specialized effector populations, rather than merely increasing cell number. Considering all three features helps distinguish developmental progression from expansion alone and clarifies how cell identity emerges during blood-cell production.
The pathway supports production of monocytes, macrophages, dendritic cells, granulocytes, and other effector populations. Together, these outputs provide cellular capabilities for pathogen recognition, inflammatory mediator production, early host defense, and tissue repair. Examining the resulting population mix therefore connects developmental regulation with the functional composition of innate immune responses.
Infection and inflammation can alter myeloid cell populations, making differentiation relevant to how immune compartments are established and reshaped. Studying these changes helps investigators relate developmental regulation to shifts in innate immune capacity, including pathogen recognition and inflammatory mediator production. This perspective helps explain why the cellular composition of host defense may change under immune challenge.
A useful assessment considers sequential gene-expression changes, progenitor proliferation, maturation, and the appearance of lineage-associated populations. Researchers can then relate these developmental features to the emergence of monocytes, macrophages, dendritic cells, granulocytes, or other effector populations. This approach connects measurable changes in cell development with the immune functions those populations support.
Research on this process helps identify how myeloid populations are established and how infection or inflammation may modify them. Those findings provide context for improving vaccines and antimicrobial responses because the resulting cells contribute to pathogen recognition, inflammatory mediator production, and early host defense. The same knowledge can also guide investigation of therapies that target immune-cell development.
The resulting myeloid populations contribute not only to early defense against pathogens but also to tissue repair. Studying their development therefore links cell production and maturation with two complementary outcomes: responding to infection and supporting recovery of affected tissues. This connection is relevant when interpreting immune responses in which inflammation, host protection, and repair occur within the same biological context.